[en] Two unrelated children presenting with episodic isolated peripheral weakness were found to have pyruvate dehydrogenase (PDH) deficiency (OMIM 312170) due to previously undescribed mutations (Pro250Thr, Arg88Cys) in the gene for the E1alpha subunit (PDHA1). Taken in context with the literature, these patients suggest that acute weakness initially resembling Guillain-Barre syndrome is a potentially reversible and probably underdiagnosed manifestation of PDH deficiency and that peripheral nerve function should be evaluated in PDH-deficient patients.
Bindoff LA, Birch-Machin MA, Farnsworth L, Gardner-Medwin D, Lindsay JG, Turnbull DM (1989) Familial intermittent ataxia due to defect of the E1 component of pyruvate dehydrogenase complex. J Neurol Sci 93:311-318
Blass JP, Avigan J, Uhlendorf BW (1970) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423-432
Bonne G, Benelli C, De Meirleir L, Lissens W, Chaussain M, Diry M, Clot JP, Ponsot G, Geoffroy V, Leroux JP (1993) E1 pyruvate dehydrogenase deficiency in a child with motor neuropathy. Pediatr Res 33:284-288
Cameron JM, Levandovskiy V, MacKay N, Tein I, Robinson BH (2004) Deficiency of pyruvate dehydrogenase caused by novel and known mutations in the E1α subunit. Am J Med Genet 131:59-66
Chabrol B, Mancini J, Benelli C, Gire C, Munnich A (1994) Leigh syndrome: pyruvate dehydrogenase defect. A case with peripheral neuropathy. J Child Neurol 9:52-55
Dahl H-HM (1995) Pyruvate dehydrogenase E1α deficiency: males and females differ yet again. Am J Hum Genet 56:553-557
Di Rocco M, Doria Lamba L, Minniti G, Caruso U, Naito E (2000) Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency. Eur J Pediatr Neurol 4:115-117
Endo H, Hasegawa K, Narisawa K, Tada K, Kagawa Y, Ohta S (1989) Defective gene in lactic acidosis: abnormal pyruvate dehydrogenase E1α subunit caused by a frameshift. Am J Hum Genet 44:358-364
Evans OB (1984) Episodic weakness in pyruvate decarboxylase deficiency. J Pediatr 105:961-963
Frederico A, Dotti MT, Fabrizi GM, Palmeri S, Massimo L, Robinson BH, Malandrini A, Guazzi GC (1990) Congenital lactic acidosis due to a defect of pyruvate dehydrogenase complex (E1). Clinical, biochemical, nerve biopsy study and effect of therapy. Eur Neurol 30:123-127
Head RA, de Goede CGEL, Newton RWN, Walter JH, McShane MA, Brown RM, Brown GK (2004) Pyruvate dehydrogenase deficiency presenting as dystonia in childhood. Dev Med Child Neurol 46:710-712
Kinoshita H, Sakuragawa N, Tada H, Naito E, Kuroda Y (1997) Recurrent muscle weakness and ataxia in thiamine-responsive pyruvate dehydrogenase complex deficiency. J Child Neurol 12:141-144
Levin KH (2004) Variants and mimics of Guillain-Barré syndrome. Neurologist 2:61-74
Lissens W, De Meirleir L, Seneca S, Liebars I, Brown GK, Brown RM, Ito M, Naito E, Kuroda Y, Kerr DS, Wexler ID, Patel MS, Robinson BH, Seyda A (2000) Mutations in the X-linked pyruvate dehydrogenase E1α subunit gene in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 15:209-219
Livingstone IR, Gardner-Medwin D, Pennington RJT (1984) Familial intermittent ataxia with possible X-linked recessive inheritance. J Neurol Sci 64:89-97
Marsac C, Benelli C, Desguerre I, Diry M, Fouque F, De Meirleir, Ponsot G, Seneca S, Poggi F, Saudubray JM, Zabot MT, Fontan D, Lissens W (1997) Biochemical and genetic studies of four patients with pyruvate dehydrogenase E1α deficiency. Hum Genet 99:785-792
Mellick G, Price L, Boyle R (2004) Late-onset presentation of pyruvate dehydrogenase deficiency. Mov Disord 19:727-729
Naito E, Ito M, Yokota I, Saijo T, Matsuda J, Ogawa Y, Kitamura S, Takada E, Horii Y, Kuroda Y (2002) Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region. Biochim Biophys Acta 1588:79-84
Naito E, Ito M, Yokota I, Saijo T, Ogawa Y, Kuroda Y (2002) Diagnosis and molecular analysis of three male patients with thiamine-responsive pyruvate dehydrogenase complex deficiency. J Neurol Sci 201:33-37
Old SE, De Vivo DC (1989) Pyruvate dehydrogenase complex deficiency: biochemical and immunoblot analysis of cultured skin fibroblasts. Ann Neurol 126:746-751
Robinson BH, MacMillan H, Petrova-Benedict R, Sherwood WG (1987) Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex. J Pediatr 111:525-533
Robinson BH (2001) Lactic acidemia (disorders of pyruvate carboxylase, pyruvate dehydrogenase). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 2275-2295
Royden Jones JH, Harmon RL, Harper CM, Bolton CF (1996) An approach to pediatric electromyography. In: Royden Jones JH, Bolton CF, Harper CM (eds) Pediatric clinical electromyography. Lippincott-Raven, Philadelphia, pp 1-37
Royden Jones JH (1996) Childhood Guillain-Barre syndrome: clinical presentation, diagnosis, and therapy. J Child Neurol 11:4-12
Sheu KF, Hu CW, Utter MF (1981) Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts. J Clin Invest 67:1463-1471
Tulinius M, Darin N, Wiklund LM, Holmberg E, Eriksson JE, Lissens W, De Meirleir L, Holme E (2005) A family with pyruvate dehydrogenase complex deficiency due to a novel C>T substitution at nucleotide position 407 in exon 4 of the X-linked E1α gene. Eur J Pediatr 164:99-103
Weber TA, Antognetti MR, Stacpoole PW (2001) Caveats when considering ketogenic diets for the treatment of pyruvate dehydrogenase complex deficiency. J Pediatr 138:390-395
Wexler ID, Hemalatha SG, McConnell J, Buist NR, Dahl H-HM, Berry SA, Cederbaum SD, Patel MS, Kerr DS (1997) Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 49:1655-1661
